Chest Unit, Kings College Hospital, London.
Br J Clin Pharmacol. 1974 Oct;1(5):399-404. doi: 10.1111/j.1365-2125.1974.tb00276.x.
1 The effects of intravenous infusion of prostaglandin E(2) (PGE(2)) on forced expiratory volume in 1 second (FEV(1)) were studied in ten asthmatic patients and compared with the effects of intravenous salbutamol. 2 PGE(2) at infusion rates of 5, 10 and 20 μg/min for three 15 min periods resulted in a small bronchodilator effect in four patients, bronchoconstriction in four, and had no measurable effect on FEV(1) in two patients; side effects were frequent and it was concluded that PGE(2) was unsuitable for use in the management of attacks of asthma. 3 In the same subjects bronchodilatation occurred during infusion of salbutamol at flow rates of 5, 10 and 20 μg/min (six patients), 10, 20 and 40 μg/min (two patients) and 20, 40 and 80 μg/min (two patients). Serious cardiovascular effects were not encountered at flow rates of less than 20 μg/minute.
研究了前列腺素 E(2)(PGE(2))静脉输注对 10 例哮喘患者第 1 秒用力呼气量(FEV(1))的影响,并与静脉沙丁胺醇的影响进行了比较。
PGE(2)以 5、10 和 20μg/min 的输注速率输注 3 个 15 分钟周期,导致 4 例患者出现小支气管扩张作用,4 例患者出现支气管收缩,2 例患者对 FEV(1)无明显影响;副作用频繁,因此得出结论,PGE(2)不适合用于哮喘发作的治疗。
在同一组受试者中,沙丁胺醇以 5、10 和 20μg/min(6 例)、10、20 和 40μg/min(2 例)和 20、40 和 80μg/min(2 例)的流速输注时出现支气管扩张。在低于 20μg/min 的流速下未遇到严重的心血管副作用。